Left ventricular remodeling in swine after myocardial infarction: A transcriptional genomics approach

Basic Research in Cardiology

Volumn 106, Issue 6, 2011, Pages 1269-1281

  Kuster, Diederik W D ^a,b   Merkus, Daphne ^a   Kremer, Andreas ^a   Van Ijcken, Wilfred F J ^a   De Beer, Vincent J ^a   Verhoeven, Adrie J M ^a,b   Duncker, Dirk J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Animal models of human diseases; Hypertrophy; Microarray; Myocardial infarction; Systolic dysfunction; Transcription factors

Indexed keywords

CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 2; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA BINDING; DNA PROBE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENOME ANALYSIS; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE REMODELING; MICROARRAY ANALYSIS; NONHUMAN; PHARMACOLOGICAL BLOCKING; PROMOTER REGION; PROTEIN DNA INTERACTION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SWINE; UPREGULATION;

ANIMALS; COUP TRANSCRIPTION FACTOR II; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FEMALE; GENE EXPRESSION PROFILING; GENOMICS; MALE; MYOCARDIAL INFARCTION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, GLUCOCORTICOID; SWINE; TRANSCRIPTION FACTORS; VENTRICULAR REMODELING;

EID: 84856697775     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-011-0229-1     Document Type: Article

References (68)

1. Brady JP, Kantorow M, Sax CM, Donovan DM, Piatigorsky J (1995) Murine transcription factor alpha A-crystallin binding protein I. Complete sequence, gene structure, expression, and functional inhibition via antisense RNA. J Biol Chem 270:1221-1229. doi:10.1074/jbc.270.3.1221
2. Cadepond F, Ulmann A, Baulieu EE (1997) RU486 (mifepristone): mechanisms of action and clinical uses. Annu Rev Med 48:129-156. doi:10.1146/annurev. med.48.1.129 (Pubitemid 27101820)
3. Chorianopoulos E, Heger T, Lutz M, Frank D, Bea F, Katus HA, Frey N (2010) FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK. Basic Res Cardiol 105:301-313. doi:10.1007/s00395-009-0046-y
4. Colbert MC, Hall DG, Kimball TR, Witt SA, Lorenz JN, Kirby ML, Hewett TE, Klevitsky R, Robbins J (1997) Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice. J Clin Invest 100:1958-1968. doi:10.1172/JCI119727 (Pubitemid 27459349)
5. Conraads VM, Vrints CJ, Rodrigus IE, Hoymans VY, Van Craenenbroeck EM, Bosmans J, Claeys MJ, Van Herck P, Linke A, Schuler G, Adams V (2010) Depressed expression of MuRF1 and MAFbx in areas remote of recent myocardial infarction: a mechanism contributing to myocardial remodeling? Basic Res Cardiol 105:219-226. doi:10.1007/s00395-009-0068-5
6. Couture O, Callenberg K, Koul N, Pandit S, Younes R, Hu ZL, Dekkers J, Reecy J, Honavar V, Tuggle C (2009) ANEXdb: an integrated animal ANnotation and microarray EXpression database. Mamm Genome 20:768-777. doi:10.1007/s00335-009- 9234-1
7. Davis FJ, Gupta M, Camoretti-Mercado B, Schwartz RJ, Gupta MP (2003) Calcium/calmodulin-dependent protein kinase activates serum response factor transcription activity by its dissociation from histone deacetylase, HDAC4. Implications in cardiac muscle gene regulation during hypertrophy. J Biol Chem 278:20047-20058. doi:10.1074/jbc. M209998200 (Pubitemid 36799198)
8. Davis FJ, Pillai JB, Gupta M, Gupta MP (2005) Concurrent opposite effects of trichostatin A, an inhibitor of histone deacetylases, on expression of alpha-MHC and cardiac tubulins: implication for gain in cardiac muscle contractility. Am J Physiol Heart Circ Physiol 288: H1477-H1490. doi:10.1152/ajpheart.007 89.2004 (Pubitemid 40270060)
9. Dhakshinamoorthy S, Jain AK, Bloom DA, Jaiswal AK (2005) Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD (P) H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants. J Biol Chem 280:16891-16900. doi:10.1074/jbc. M500166200 (Pubitemid 41389148)
10. Dixon JA, Spinale FG (2009) Large animal models of heart failure: a critical link in the translation of basic science to clinical practice. Circ Heart Fail 2:262-271. doi:10.1161/CIRCHE ARTFAILURE.108.814459
11. Duncker DJ, Boontje NM, Merkus D, Versteilen A, Krysiak J, Mearini G, El Armouche A, de Beer VJ, Lamers JM, Carrier L, Walker LA, Linke WA, Stienen GJ, van der Velden J (2009) Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodeling. Circ Heart Fail 2:233-242. doi:10.1161/CIRCHEARTFAILURE.108.806125
12. Elsaesser F, Parvizi N, Ellendorff F (1978) Steroid feedback on luteinizing hormone secretion during sexual maturation in the pig. J Endocrinol 78:329-342. doi:10.1677/joe.0.0780329 (Pubitemid 9034205)
13. Freire CM, Azevedo PS, Minicucci MF, Oliveira SJ, Martinez PF, Novo R, Chiuso-Minicucci F, Matsubara BB, Matsubara LS, Okoshi K, Novelli EL, Zornoff LA, Paiva SA (2011) Influence of different doses of retinoic acid on cardiac remodeling. Nutrition 27:824-828. doi:10.1016/j.nut.2010.08.011
14. Garlie JB, Hamid T, Gu Y, Ismahil MA, Chandrasekar B, Prabhu SD (2011) Tumor necrosis factor receptor 2 signaling limits betaadrenergic receptor-mediated cardiac hypertrophy in vivo. Basic Res Cardiol [ePub ahead of print]. doi:10.1007/s00395-011-0196-6
15. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80. doi:10.1186/gb-2004-5-10-r80
16. Georgopoulos K (2002) Haematopoietic cell-fate decisions, chromatin regulation and ikaros. Nat Rev Immunol 2:162-174. doi:10.1038/nri747 (Pubitemid 37328763)
17. Haghighi K, Kolokathis F, Pater L, Lynch RA, Asahi M, Gramolini AO, Fan GC, Tsiapras D, Hahn HS, Adamopoulos S, Liggett SB, Dorn GW, MacLennan DH, Kremastinos DT, Kranias EG (2003) Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J Clin Invest 111:869-876. doi:10.1172/JCI200317892 (Pubitemid 37074962)
18. Hamdani N, de Waard MC, Messer AE, Boontje NM, Kooij V, van Dijk SJ, Versteilen A, Lamberts R, Merkus D, Dos Remedios C, Duncker DJ, Borbely A, Papp Z, Paulus W, Stienen GJ, Marston SB, van der Velden J (2008) Myofilament dysfunction in cardiac disease from mice to men. J Muscle Res Cell Motil 29:189-201. doi:10.1007/s10974-008-9160-y
19. Hammoud L, Lu X, Lei M, Feng Q (2011) Deficiency in TIMP-3 increases cardiac rupture and mortality post-myocardial infarction via EGFR signaling: beneficial effects of cetuximab. Basic Res Cardiol 106:459-471. doi:10.1007/s00395-011-0196-6
20. Hannenhalli S, Putt ME, Gilmore JM, Wang J, Parmacek MS, Epstein JA, Morrisey EE, Margulies KB, Cappola TP (2006) Transcriptional genomics associates FOX transcription factors with human heart failure. Circulation 114:1269-1276. doi:10.1161/CIRCULATIONAHA.106.632430 (Pubitemid 44402052)
21. Hasenfuss G (1998) Animal models of human cardiovascular disease, heart failure and hypertrophy. Cardiovasc Res 39:60-76. doi:10.1016/S0008-6363(98) 00110-2 (Pubitemid 28322380)
22. Heineke J, Ruetten H, Willenbockel C, Gross SC, Naguib M, Schaefer A, Kempf T, Hilfiker-Kleiner D, Caroni P, Kraft T, Kaiser RA, Molkentin JD, Drexler H, Wollert KC (2005) Attenuation of cardiac remodeling after myocardial infarction by muscle LIM protein-calcineurin signaling at the sarcomeric Z-disc. Proc Natl Acad Sci USA 102:1655-1660. doi:10.1073/pnas. 0405488102 (Pubitemid 40209223)
23. Heusch G, Schulz R (2011) A radical view on the contractile machinery in human heart failure. J Am Coll Cardiol 57:310-312. doi:10.1016/j.jacc.2010.06. 057
24. Ito T, Fujio Y, Takahashi K, Azuma J (2007) Degradation of NFAT5, a transcriptional regulator of osmotic stress-related genes, is a critical event for doxorubicin-induced cytotoxicity in cardiac myocytes. J Biol Chem 282:1152-1160. doi:10.1074/jbc. M609547200 (Pubitemid 47076570)
25. Javadov S, Rajapurohitam V, Kilic A, Hunter JC, Zeidan A, Said Faruq N, Escobales N, Karmazyn M (2011) Expression of mitochondrial fusion-fission proteins during post-infarction remodeling: the effect of NHE-1 inhibition. Basic Res Cardiol 106:99-109. doi:10.1007/s00395-010-0122-3
26. Kass DA, Hare JM, Georgakopoulos D (1998) Murine cardiac function: a cautionary tail. Circ Res 82:519-522 (Pubitemid 28117334)
27. Katz AM (2008) The "modern" view of heart failure: how did we get here? Circ Heart Fail 1:63-71. doi:10.1161/CIRCHEAR TFAILURE.108.772756
28. Kawano S, Kubota T, Monden Y, Tsutsumi T, Inoue T, Kawamura N, Tsutsui H, Sunagawa K (2006) Blockade of NF-kappaB improves cardiac function and survival after myocardial infarction. Am J Physiol Heart Circ Physiol 291: H1337-H1344. doi:10.1152/ajpheart.01175.2005 (Pubitemid 44343679)
29. Kel A, Voss N, Jauregui R, Kel-Margoulis O, Wingender E (2006) Beyond microarrays: find key transcription factors controlling signal transduction pathways. BMC Bioinformatics 7 (Suppl 2): S13. doi:10.1186/1471-2105-7-S2-S13 (Pubitemid 46442966)
30. Kel A, Voss N, Valeev T, Stegmaier P, Kel-Margoulis O, Wingender E (2008) ExPlain: finding upstream drug targets in disease gene regulatory networks. SAR QSAR Environ Res 19:481-494. doi:10.1080/10629360802083806
31. Kleinbongard P, Heusch G, Schulz R (2010) TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol Ther 127:295-314. doi:10.1016/j.pharmthera.2010.05.002
32. Krusche CA, Holthofer B, Hofe V, van de Sandt AM, Eshkind L, Bockamp E, Merx MW, Kant S, Windoffer R, Leube RE (2011) Desmoglein 2 mutant mice develop cardiac fibrosis and dilation. Basic Res Cardiol 106:617-633. doi:10.1007/s00395-011-0175-y
33. Kuster DW, Merkus D, Jorna HJ, Dekkers DH, Duncker DJ, Verhoeven AJ (2011) Nuclear protein extraction from frozen porcine myocardium. J Physiol Biochem 67:165-173
34. McSweeney SJ, Hadoke PW, Kozak AM, Small GR, Khaled H, Walker BR, Gray GA (2010) Improved heart function follows enhanced inflammatory cell recruitment and angiogenesis in 11betaHSD1-deficient mice post-MI. Cardiovasc Res 88:159-167. doi:10.1093/cvr/cvq149
35. Mito S, Ozono R, Oshima T, Yano Y, Watari Y, Yamamoto Y, Brydun A, Igarashi K, Yoshizumi M (2008) Myocardial protection against pressure overload in mice lacking Bach1, a transcriptional repressor of heme oxygenase-1. Hypertension 51:1570-1577. doi:10.1161/HYPERTENSIONAHA.107.102566
36. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215-228. doi:10.1016/S0092-8674(00) 81573-1 (Pubitemid 28180855)
37. Morancho B, Minguillon J, Molkentin JD, Lopez-Rodriguez C, Aramburu J (2008) Analysis of the transcriptional activity of endogenous NFAT5 in primary cells using transgenic NFAT-luciferase reporter mice. BMC Mol Biol 9:13. doi:10.1186/1471-2199-9-13 (Pubitemid 351344696)
38. Mudd JO, Kass DA (2008) Tackling heart failure in the twentyfirst century. Nature 451:919-928. doi:10.1038/nature06798 (Pubitemid 351301747)
39. Neuhold LA, Wold B (1993) HLH forced dimers: tethering MyoD to E47 generates a dominant positive myogenic factor insulated from negative regulation by Id. Cell 74:1033-1042. doi:10.1016/0092-8674(93) 90725-6 (Pubitemid 23289460)
40. Nian M, Lee P, Khaper N, Liu P (2004) Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 94:1543-1553. doi:10.1161/01. RES.0000130526.20854.fa (Pubitemid 38856961)
41. Ohno M, Zannini M, Levy O, Carrasco N, di Lauro R (1999) The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription. Mol Cell Biol 19:2051-2060 (Pubitemid 29098263)
42. Ohtani T, Mano T, Hikoso S, Sakata Y, Nishio M, Takeda Y, Otsu K, Miwa T, Masuyama T, Hori M, Yamamoto K (2009) Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure. J Hypertens 27:1074-1083. doi:10.1097/HJH.0b013e328326cb04
43. Pereira AM, Delgado V, Romijn JA, Smit JW, Bax JJ, Feelders RA (2010) Cardiac dysfunction is reversed upon successful treatment of Cushing's syndrome. Eur J Endocrinol 162:331-340. doi:10.1530/EJE-09-0621
44. Pereira FA, Tsai MJ, Tsai SY (2000) COUP-TF orphan nuclear receptors in development and differentiation. Cell Mol Life Sci 57:1388-1398. doi:10.1007/PL00000624
45. Ringner M (2008) What is principal component analysis? Nat Biotechnol 26:303-304. doi:10.1038/nbt0308-303 (Pubitemid 351355122)
46. Sack MN, Disch DL, Rockman HA, Kelly DP (1997) A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program. Proc Natl Acad Sci USA 94:6438-6443. doi:10.1073/pnas.94.12.6438 (Pubitemid 27270703)
47. Saygili E, Rana OR, Meyer C, Gemein C, Andrzejewski MG, Ludwig A, Weber C, Schotten U, Kruttgen A, Weis J, Schwinger RH, Mischke K, Rassaf T, Kelm M, Schauerte P (2009) The angiotensin-calcineurin-NFAT pathway mediates stretch-induced up-regulation of matrix metalloproteinases-2/-9 in atrial myocytes. Basic Res Cardiol 104:435-448. doi:10.1007/s00395-008-0772-6
48. Schoenauer R, Emmert MY, Felley A, Ehler E, Brokopp C, Weber B, Nemir M, Faggian GG, Pedrazzini T, Falk V, Hoerstrup SP, Agarkova I (2011) EH-myomesin splice isoform is a novel marker for dilated cardiomyopathy. Basic Res Cardiol 106:233-247. doi:10.1007/s00395-010-0131-2
49. Simon R, Lam A, Li MC, Ngan M, Menenzes S, Zhao Y (2007) Analysis of gene expression data using BRB-ArrayTools. Cancer Inform 3:11-17 (Pubitemid 47075796)
50. Small GR, Hadoke PW, Sharif I, Dover AR, Armour D, Kenyon CJ, Gray GA, Walker BR (2005) Preventing local regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 enhances angiogenesis. Proc Natl Acad Sci U S A 102:12165-12170. doi:10.1073/pnas.0500641102 (Pubitemid 41291146)
51. Sorop O, Merkus D, de Beer VJ, Houweling B, Pistea A, McFalls EO, Boomsma F, van Beusekom HM, van der Giessen WJ, Van Bavel E, Duncker DJ (2008) Functional and structural adaptations of coronary microvessels distal to a chronic coronary artery stenosis. Circ Res 102:795-803. doi:10.1161/CIRCRE SAHA.108.172528 (Pubitemid 351521594)
52. Spinale FG (2007) Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 87:1285-1342. doi:10.1152/physrev. 00012.2007 (Pubitemid 350041472)
53. Srivastava S, Chandrasekar B, Bhatnagar A, Prabhu SD (2002) Lipid peroxidation-derived aldehydes and oxidative stress in the failing heart: role of aldose reductase. Am J Physiol Heart Circ Physiol 283: H2612-H2619. doi:10.1152/ajpheart.00592.2002 (Pubitemid 35345970)
54. Sutton MG, Sharpe N (2000) Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101:2981-2988. doi:10.1161/01. CIR.101.25.2981 (Pubitemid 30415891)
55. Tapscott SJ (2005) The circuitry of a master switch: MyoD and the regulation of skeletal muscle gene transcription. Development 132:2685-2695. doi:10.1242/dev. 01874 (Pubitemid 40932860)
56. Thackaberry EA, Gabaldon DM, Walker MK, Smith SM (2002) Aryl hydrocarbon receptor null mice develop cardiac hypertrophy and increased hypoxia-inducible factor-1alpha in the absence of cardiac hypoxia. Cardiovasc Toxicol 2:263-274. doi:10.1385/CT:2:4:263 (Pubitemid 37070567)
57. van der Velden J, Merkus D, Klarenbeek BR, James AT, Boontje NM, Dekkers DH, Stienen GJ, Lamers JM, Duncker DJ (2004) Alterations in myofilament function contribute to left ventricular dysfunction in pigs early after myocardial infarction. Circ Res 95: e85-e95. doi:10.1161/01. RES.0000149531.02904.09
58. van Kats JP, Duncker DJ, Haitsma DB, Schuijt MP, Niebuur R, Stubenitsky R, Boomsma F, Schalekamp MA, Verdouw PD, Danser AH (2000) Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II. Circulation 102:1556-1563. doi:10.1161/01. CIR.102. 13.1556
59. Velagaleti RS, Pencina MJ, Murabito JM, Wang TJ, Parikh NI, D'Agostino RB, Levy D, Kannel WB, Vasan RS (2008) Longterm trends in the incidence of heart failure after myocardial infarction. Circulation 118:2057-2062. doi:10.1161/CIRCULAT IONAHA.108.784215
60. Venkatesan B, Valente AJ, Prabhu SD, Shanmugam P, Delafontaine P, Chandrasekar B (2010) EMMPRIN activates multiple transcription factors in cardiomyocytes, and induces interleukin-18 expression via Rac1-dependent PI3 K/Akt/IKK/NF-kappaB and MKK7/JNK/AP-1 signaling. J Mol Cell Cardiol 49:655-663. doi:10.1016/j.yjmcc.2010.05.007
61. Wei L, MacDonald TM, Walker BR (2004) Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 141:764-770
62. Werner JC, Sicard RE, Hansen TW, Solomon E, Cowett RM, Oh W (1992) Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia. J Pediatr 120:286-291. doi:10.1016/S0022-3476(05) 80446-9
63. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ (1987) Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76:44-51. doi:10.1161/01. CIR.76.1.44 (Pubitemid 17093191)
64. Wingender E, Chen X, Hehl R, Karas H, Liebich I, Matys V, Meinhardt T, Pruss M, Reuter I, Schacherer F (2000) TRANS-FAC: an integrated system for gene expression regulation. Nucleic Acids Res 28:316-319. doi:10.1093/nar/28.1.316 (Pubitemid 30047792)
65. Wong SC, Fukuchi M, Melnyk P, Rodger I, Giaid A (1998) Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure. Circulation 98:100-103. doi:10.1161/01. CIR.98.2.100 (Pubitemid 28317888)
66. Zhang J, Duncker DJ, Ya X, Zhang Y, Pavek T, Wei H, Merkle H, Ugurbil K, From AH, Bache RJ (1995) Effect of left ventricular hypertrophy secondary to chronic pressure overload on transmural myocardial 2-deoxyglucose uptake. A 31P NMR spectroscopic study. Circulation 92:1274-1283. doi:10.1161/01. CIR.92.5.1274
67. Zhang X, Azhar G, Chai J, Sheridan P, Nagano K, Brown T, Yang J, Khrapko K, Borras AM, Lawitts J, Misra RP, Wei JY (2001) Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor. Am J Physiol Heart Circ Physiol 280: H1782-H1792
68. Zhou MD, Sucov HM, Evans RM, Chien KR (1995) Retinoiddependent pathways suppress myocardial cell hypertrophy. Proc Natl Acad Sci U S A 92:7391-7395. doi:10.1073/pnas.92.16.7391